Clinical Trial Update: A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating SI-B003 alone and in combination with BL-B01D1 in patients with locally advanced or metastatic urothelial carcinoma and other solid t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor
• Urothelial Carcinoma

Drugs mentioned

• BL-B01D1
• SI-B003

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Urothelial Carcinoma, Solid Tumor | Phase 2 | Status: RECRUITING